Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Basal Cell 3 Prostatic Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Recurrence 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Microphthalmia, Isolated, with Coloboma 5 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myeloid 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Blast Crisis 1

Interventions

Gemcitabine 34 pembrolizumab 27 Paclitaxel 21 Cyclophosphamide 21 Docetaxel 20 Carboplatin 20 Irinotecan 19 Capecitabine 19 Fluorouracil 17 Bevacizumab 15 Dexamethasone 14 fludarabine 13 Oxaliplatin 13 Leucovorin 13 Blood Specimen Collection 13 Everolimus 12 Cetuximab 12 Ipilimumab 11 Erlotinib Hydrochloride 11 Rituximab 10 Pemetrexed 10 Cisplatin 10 venetoclax 9 Temozolomide 9 Sunitinib 9 Nivolumab 9 Trastuzumab 8 Interleukin-2 8 aldesleukin 7 Epoetin Alfa 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasms × HhAntag691 × Clear all

NCT01096732 2014-01-08

HIPPoS

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Terminated

Adenocarcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡